FDA 510(k)

ADVIA Centaur CEA Assay

K-Number: K200215 · 2020-04-13

ApplicantSiemens Healthcare Disgnostics, Inc.

Decision Date2020-04-13

Product CodeDHX

Advisory CommitteeIM

DecisionSubstantially Equivalent

Device Summary

ADVIA Centaur CEA Assay is the device name listed in this FDA 510(k) record. The listed applicant is Siemens Healthcare Disgnostics, Inc.. It received FDA 510(k) clearance on 2020-04-13 under 510(k) number K200215. The device is classified under product code DHX. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ADVIA Centaur CEA Assay?

ADVIA Centaur CEA Assay is a medical device that received FDA 510(k) clearance on 2020-04-13. The listed applicant is Siemens Healthcare Disgnostics, Inc.. The 510(k) number is K200215.

When did ADVIA Centaur CEA Assay receive FDA 510(k) clearance?

ADVIA Centaur CEA Assay received FDA 510(k) clearance on 2020-04-13, under 510(k) number K200215.

Who is the listed applicant for ADVIA Centaur CEA Assay?

The FDA 510(k) record lists Siemens Healthcare Disgnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ADVIA Centaur CEA Assay?

The FDA product code for ADVIA Centaur CEA Assay is DHX.

Related Devices (Code: DHX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K223921Access CEABeckman Coulter, Inc.K231517VITROS Immunodiagnostic Products CEA Reagent PackOrtho Clinical Diagnostics

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.